about
Tumor-primed NK cells: waiting for the green lightA proinflammatory peptide from Helicobacter pylori activates monocytes to induce lymphocyte dysfunction and apoptosisIndividual patient data meta-analysis of randomized trials evaluating IL-2 monotherapy as remission maintenance therapy in acute myeloid leukemia.Cytolytic T-cell response against Epstein-Barr virus in lung cancer patients and healthy subjects.Combining antiangiogenic therapy with immunotherapy exerts better therapeutical effects on large tumors in a woodchuck hepatoma modelFocus on TILs: prognostic significance of tumor infiltrating lymphocytes in human melanomaAn important role for granulocytes in the thermal regulation of colon tumor growth.Therapeutic potential of mycobacterial cell wall-DNA complexes.Armed therapeutic viruses: strategies and challenges to arming oncolytic viruses with therapeutic genes.Therapeutic vaccination with tumor cells that engage CD137.Role of the ERK pathway for oxidant-induced parthanatos in human lymphocytes.Novel approaches to therapeutic cancer vaccines.Methylcholanthrene-Induced Sarcomas Develop Independently from NOX2-Derived ROS.Peptide vaccine given with a Toll-like receptor agonist is effective for the treatment and prevention of spontaneous breast tumors.Pre-clinical toxicity assessment of tumor-targeted interleukin-12 low-intensity electrogenetherapy.CD3-mediated activation of tumor-reactive lymphocytes from patients with advanced cancerExpansion of melanoma-specific cytolytic CD8+ T cell precursors in patients with metastatic melanoma vaccinated with CD34+ progenitor-derived dendritic cells.Efficacy of adjuvant immunotherapy with cytokine-induced killer cells in patients with locally advanced gastric cancer.Tumor Presence Induces Global Immune Changes and Enhances Nanoparticle ClearanceThe effect of peripheral blood lymphocyte stimulation on zeta chain expression and IL-2 production in Hodgkin's disease.Effector CD8+CD45RO-CD27-T cells have signalling defects in patients with squamous cell carcinoma of the head and neck.Modulation of human Valpha24(+)Vbeta11(+) NKT cells by age, malignancy and conventional anticancer therapies.Novel antibodies as anticancer agents.Signaling defects in anti-tumor T cellsA pharmacologic perspective on newly emerging T-cell manipulation technologies.VEGF-mediated cross-talk within the neonatal murine thymus.Enhancement of CD4+ T cell activities and modulation of Th1/Th2 lineage development in radiated tumor-bearing rats treated with male zooid of Antheraea pernyi extracts.Role of prolactin receptor and CD25 in protection of circulating T lymphocytes from apoptosis in patients with breast cancer.Enhanced function of cytotoxic T lymphocytes induced by dendritic cells modified with truncated PSMA and 4-1BBL.Adjuvant treatment combining cellular immunotherapy with chemotherapy improves the clinical outcome of patients with stage II/III gastric cancerTumour, Oxidative Stress and Host T Cell Response: Cementing the Dominance.Extracellular 2'5'-oligoadenylate synthetase 2 mediates T-cell receptor CD3-ζ chain down-regulation via caspase-3 activation in oral cancer.Effect of cytokine-induced killer cells on immune function in patients with lung cancer.Andrographolide, a potential cancer therapeutic agent isolated from Andrographis paniculata.DNA vaccination for prostate cancer, from preclinical to clinical trials - where we stand?PC-3 prostate carcinoma cells release signal substances that influence the migratory activity of cells in the tumor's microenvironment.Expression of macrophage migration inhibitory factor by neuroblastoma leads to the inhibition of antitumor T cell reactivity in vivo.A hepatitis C virus-encoded, nonstructural protein (NS3) triggers dysfunction and apoptosis in lymphocytes: role of NADPH oxidase-derived oxygen radicals.Activation of cytotoxic lymphocytes by interferon-alpha: role of oxygen radical-producing mononuclear phagocytes.Adenosine acts through an A3 receptor to prevent the induction of murine anti-CD3-activated killer T cells.
P2860
Q26999306-D851B84D-1D0E-417B-A61E-FF315550C22EQ28361854-3F559239-5D54-4587-96B6-592B2D973D23Q33881750-5C6D73B4-1C17-4295-9ADB-E794FE9EC6F2Q34010871-BDC95C50-6852-45A5-9C1D-B6FD902C05CFQ34093354-2D00535A-8A38-462E-8E38-6DC89952887DQ34111789-3F0A2D26-6700-4C57-9331-F701C2C4D6CBQ34293611-65EDA503-E897-4A80-AE83-E77227AE537EQ34481895-3731E239-3762-4424-9456-A741502290B1Q35043106-9AF8D3D7-1B78-4690-A06F-1E88D9FA45D9Q35071688-BBBFD800-1120-4D26-BAD5-4D0E41997E86Q35107809-E2882E13-A56D-45CF-A216-B8D496CC87AAQ35623327-EF3161EA-21AE-46D3-AC79-E451A00986F4Q35663908-46D975B6-0CD8-4779-ADAE-F2006DEF52E7Q36007167-B6887D18-FC1F-4B10-8376-8BA47C99770DQ36152019-6E039599-BD66-47D2-A9D7-E7160658E6D2Q36235825-FFE0BD24-0793-41B4-95B6-461F0FDF7371Q36399108-2D672C7F-F5F2-42D7-A6EA-0233AB897694Q36422925-F765B7D7-4B3E-4C98-99A7-02C408DC345CQ36600153-07EB108F-FA27-42EB-A608-907FCE829EC2Q36622284-80849F52-9E54-4EAE-A88A-2E7AD24723D4Q36648706-689F4D1C-3B6E-4B24-89C6-8412D74F8F51Q36695207-ED13C4A5-842B-4CB8-B0D4-9E133644C049Q36832141-B12DE94B-F92D-44FF-B41C-6E9BECE121ACQ37063739-CA253557-07F0-40E9-B398-78229AE4A4D5Q37064737-46C9060A-549A-404C-A54F-2C99F017DE36Q37142168-C6853526-86BA-480C-87D3-C62271241C6EQ37240429-F8E673F3-B74A-4B04-AAFA-C9EC87CCED65Q37355075-7B54D0E4-A958-43D1-83B0-50CED5FD9929Q37521861-B36B352E-678C-42E2-83D9-AE69186DF7C2Q37609431-B94BE9DF-B4B1-4C58-AE75-CCFD5F082DD0Q38569178-6FB56705-2F84-4670-B0F1-E96C26507315Q38817649-45455458-882C-4CDE-A795-394191BC1230Q39651813-119812CD-7F40-4860-810D-E31DBE831113Q40612365-B491FA8A-FC0C-48E3-9A2C-22BD1182E471Q41561252-A4B5916A-9B82-43B5-BA9F-4FBDA75A6FC2Q42650190-62FD4FBF-981A-49B4-94C9-0D467F523B69Q42940126-2A494399-4867-4CF1-A5A0-9EFC51520EB6Q42987619-068A0E76-6E2C-49F9-AFF6-7DFC7F9308FAQ43460755-D24DCA14-9B49-4490-8096-2BD67CBC313EQ43981136-B2C8680A-DD2C-4D02-B0DF-623C6B8261CB
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Tumor-induced immune dysfunction.
@ast
Tumor-induced immune dysfunction.
@en
type
label
Tumor-induced immune dysfunction.
@ast
Tumor-induced immune dysfunction.
@en
prefLabel
Tumor-induced immune dysfunction.
@ast
Tumor-induced immune dysfunction.
@en
P2093
P356
P1476
Tumor-induced immune dysfunction.
@en
P2093
Horiguchi S
Kiessling R
Petersson M
Wasserman K
P2888
P304
P356
10.1007/S002620050586
P577
1999-10-01T00:00:00Z
P6179
1017204190